AMANDA HILL: Open Payments
NPI 1669990040 · CLEVELAND, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,122 in 61 payments from 9 companies in 2025. Trend: 2023 $841 · 2024 $821 · 2025 $1,122
Food & beverage: $1,122
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $415 |
| Abbott Laboratories | 23 | $326 |
| Janssen Biotech, Inc. | 5 | $117 |
| Lilly USA, LLC | 5 | $89 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $76 |
| Philips North America LLC | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
Products named: RINVOQ, HI-TORQUE COMMAND, TREMFYA, DIAMONDBACK PERIPHERAL, OMVOH, EMBOSHIELD NAV6, LINZESS, SKYRIZI.
Industry payments across MS — which companies pay providers there.
